Abnormal glucose metabolism and high-energy expenditure in idiopathic pulmonary arterial hypertension

Annals of the American Thoracic Society

Volumn 14, Issue 2, 2017, Pages 190-199

  Heresi, Gustavo A ^a   Malin, Steven K ^b   Barnes, Jarrod W ^b   Tian, Liping ^b   Kirwan, John P ^b   Dweik, Raed A ^a,b  

^a Respiratory Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Energy expenditure; Glucose metabolism disorder; Pulmonary hypertension

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY COMPUTED TOMOGRAPHY; ENERGY EXPENDITURE; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIRECT CALORIMETRY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PULMONARY HYPERTENSION; RESTING ENERGY EXPENDITURE; SIX MINUTE WALK TEST; VASCULAR DISEASE; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; ENERGY METABOLISM; GLUCOSE TOLERANCE TEST; METABOLISM; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PROPORTIONAL HAZARDS MODEL; UNITED STATES; WALK TEST;

ABSORPTIOMETRY, PHOTON; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; ENERGY METABOLISM; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UNITED STATES; WALK TEST;

EID: 85014778208     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201608-605OC     Document Type: Article

References (54)

1. Humbert M, Lau EM, Montani D, Jäs X, Sitbon O, Simonneau G. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation 2014;130: 2189-2208.
2. Ryan JJ, Archer SL. Emerging concepts in the molecular basis of pulmonary arterial hypertension. I. Metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension. Circulation 2015;131: 1691-1702.
3. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115:165-175.
4. Humbert M, Sitbon O, Yäci A, Montani D, O'Callaghan DS, Jäs X, Parent F, Savale L, Natali D, Gü nther S, et al.; French Pulmonary Arterial Hypertension Network. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36:549-555.
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
6. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-g activation. Circulation 2007;115:1275-1284.
7. Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 2012; 35:131-136.
8. Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, Rio M, Sagan C, Savineau JP, Loirand G, Pacaud P. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol 2009;158:1285-1294.
9. West J, Niswender KD, Johnson JA, Pugh ME, Gleaves L, Fessel JP, Hemnes AR. A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J 2013;41:861-871.
10. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376-387.
11. Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012;186:790-796.
12. Burger CD, Foreman AJ, Miller DP, Safford RE, McGoon MD, Badesch DB. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Longterm PAH Disease Management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc 2011;86:105-112.
13. Heresi GA, Aytekin M, Newman J, DiDonato J, Dweik RA. Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 182:661-668.
14. Barnes JW, Tian L, Heresi GA, Farver CF, Asosingh K, Comhair SA, Aulak KS, Dweik RA. O-Linked b-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension. Circulation 2015;131:1260-1268.
15. Malin SK, Haus JM, Solomon TP, Blaszczak A, Kashyap SR, Kirwan JP. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab 2013;305:E1292-E1298.
16. Sutendra G, Kinnaird A, Dromparis P, Paulin R, Stenson TH, Haromy A, Hashimoto K, Zhang N, Flaim E, Michelakis ED. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 2014;158:84-97.
17. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(25, Suppl):D34-D41.
18. Fealy CE, Nieuwoudt S, Scelsi AR, Malin SK, Foucher JA, Pagadala M, Li M, Rocco M, Burguera B, Kirwan JP. High intensity crossfit exercise increases b-cell function and insulin sensitivity in adults with type 2 diabetes [abstract]. Diabetes 2015;64:A2014-A2015.
19. Kelly KR, Williamson DL, Fealy CE, Kriz DA, Krishnan RK, Huang H, Ahn J, Loomis JL, Kirwan JP. Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans. Metabolism 2010;59: 200-205.
20. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1-9.
21. American Diabetes Association. Standards of medical care in diabetes: 2013. Diabetes Care 2013;36:S11-S66.
22. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23:295-301.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
24. Solomon TP, Malin SK, Karstoft K, Knudsen SH, Haus JM, Laye MJ, Pedersen M, Pedersen BK, Kirwan JP. Determining pancreatic b-cell compensation for changing insulin sensitivity using an oral glucose tolerance test. Am J Physiol Endocrinol Metab 2014;307:E822-E829.
25. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA; San Antonio Metabolism Study. Beta-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) Study. Diabetologia 2004;47:31-39.
26. RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, Inc.; 2015.
27. Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant 2011;30:904-911.
28. Belly MJ, Tiede H, Morty RE, Schulz R, Voswinckel R, Tanislav C, Olschewski H, Ghofrani HA, Seeger W, Reichenberger F. HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? J Heart Lung Transplant 2012;31:1109-1114.
29. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL. Insulin resistance in pulmonary arterial hypertension. Eur Respir J 2009;33:318-324.
30. Heresi GA, Aytekin M, Newman J, Dweik RA. CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival. Lung 2010;188:191-197.
31. George PM, Oliver E, Dorfmuller P, Dubois OD, Reed DM, Kirkby NS, Mohamed NA, Perros F, Antigny F, Fadel E, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res 2014;114:677-688.
32. Ross DJ, Strieter RM, Fishbein MC, Ardehali A, Belperio JA. Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension. J Heart Lung Transplant 2012;31:865-873.
33. Sun X, Kumar S, Sharma S, Aggarwal S, Lu Q, Gross C, Rafikova O, Lee SG, Dasarathy S, Hou Y, et al. Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase. Am J Respir Cell Mol Biol 2014;50:1084-1095.
34. Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P. CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev 2014;25:57-65.
35. Paulin R, Michelakis ED. The metabolic theory of pulmonary arterial hypertension. Circ Res 2014;115:148-164.
36. Goodpaster BH. Mitochondrial deficiency is associated with insulin resistance. Diabetes 2013;62:1032-1035.
37. Fealy CE, Mulya A, Lai N, Kirwan JP. Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle. J Appl Physiol (1985) 2014;117:239-245.
38. Heresi GA, Dweik RA. Strengths and limitations of the six-minute-walk test: a model biomarker study in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:1122-1124.
39. Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003;61:397-412.
40. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-534.
41. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85:4426-4433.
42. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
43. Pak O, Sommer N, Hoeres T, Bakr A, Waisbrod S, Sydykov A, Haag D, Esfandiary A, Kojonazarov B, Veit F, et al. Mitochondrial hyperpolarization in pulmonary vascular remodeling: mitochondrial uncoupling protein deficiency as disease model. Am J Respir Cell Mol Biol 2013;49:358-367.
44. Illner K, Brinkmann G, Heller M, Bosy-Westphal A, Mü ller MJ. Metabolically active components of fat free mass and resting energy expenditure in nonobese adults. Am J Physiol Endocrinol Metab 2000;278:E308-E315.
45. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 2010;65:113-117.
46. Manders E, Ruiter G, Bogaard HJ, Stienen GJ, Vonk-Noordegraaf A, de Man FS, Ottenheijm CA. Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension. Eur Respir J 2015;45: 1737-1740.
47. Batt J, Ahmed SS, Correa J, Bain A, Granton J. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2014;50:74-86.
48. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay è , Breuils-Bonnet S, Ribeiro F, Porlier A, Maltais F, Bonnet S, et al. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med 2014;190:318-328.
49. Oudiz R, Meyer C, Chin M, Feldman J, Goldsberry A, McConnell J, McCullough P, O'Grady M, Tapson V, Torres F, et al. Initial data report from "LARIAT": a phase 2 study of bardoxolone methyl in PAH patients on stable background therapy [abstract]. Chest 2015;148:639A.
50. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246.
51. Heresi GA, Aytekin M, Hammel JP, Wang S, Chatterjee S, Dweik RA. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J 2014;43:912-914.
52. Inoue E, Ichiki T, Takeda K, Matsuura H, Hashimoto T, Ikeda J, Kamiharaguchi A, Sunagawa K. Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice. J Endocrinol 2012;213:285-291.
53. Said SA, Ammar SM, Suddek GM. Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes. Pharmacol Res 2005;51:107-115.
54. Ramirez CE, Nian H, Yu C, Gamboa JL, Luther JM, Brown NJ, Shibao CA. Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial. J Clin Endocrinol Metab 2015;100:4533-4540.